SEGMENT INFORMATION

3 Months Ended

Dec. 31, 2019

SEGMENT INFORMATION

SEGMENT INFORMATION

5.    SEGMENT INFORMATION

We operate in two principal segments - research services and research products. Our Services segment provides research and development support on a contract basis directly to pharmaceutical companies. Our Products segment provides liquid chromatography, electrochemical and physiological monitoring products to pharmaceutical companies, universities, government research centers and medical research institutions.  Our accounting policies in these segments are the same as those described in the summary of significant accounting policies found in Note 2 to Consolidated Financial Statements in our annual report on Form 10-K for the fiscal year ended September 30, 2019.

	Three Months Ended
	December 31,
	2019		2018
Revenue:
Service	$	12,142	$	7,735
Product		776		890
	$	12,918	$	8,625
Operating income (loss):
Service	$	1,263	$	636
Product		(271)		(80)
Corporate		(2,012)		(515)
	$	(1,020)	$	41
Interest expense		(311)		(126)
Other income		2		1
Loss before income taxes	$	(1,329)	$	(84)